Replies to post #169385 on Biotech Values

[mcbio]

Novo is trailing Israel's Oramed Pharmaceuticals in clinical testing of an insulin pill, sparking speculation of a possible deal. But Sorensen said this was not on the cards since Novo doubted Oramed's approach.

Interesting to see the negative comments specifically on Oramed's approach.

[DewDiligence]

Thanks for the NVO article. Funny that the Reuters author uses the phrase, “oral pills,” as though there were another kind :- )